By vgreene, 27 September, 2016 Recombinant influenza vaccines (RIV)5 are an alternative for pts ≥18 yo6,7
By vgreene, 27 September, 2016 Trivalent recombinant influenza vaccine (RIV3) is an alternative for pts ≥18 yo5,6
By vgreene, 27 September, 2016 High-dose and adjuvanted IIV formulations also available for pts ≥65 yo, however no preference given to any one formulation
By vgreene, 27 September, 2016 LAIV not recommended for any population5 and contraindicated in children
